Intracoronary brachytherapy: time to sell short?


The introduction of innovative new devices and drugs has been a major influence in the dissemination of catheter-based coronary revascularization procedures into clinical practice. Systematic appraisals of effectiveness have typically come only after regulatory approval and widespread clinical acceptance. Consideration of the potential economic implications… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics